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Trauma Care: 
When Every Second Counts 
Trauma is the leading cause of death 
among people under age 44. Skill, 
timing and teamwork are key in-
gredients in the care delivered to the 
estimated 1,200 trauma patients who 
are brought to Boston Emergency 
Medical Center each year. 
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A Classical Approach 
To Fighting Cancer 
A new "designer" drug, created 
through genetic engineering, attacks 
and kills leukemia and lymphoma 
cells. The drug, now in clinical trials, 
may be useful in fighting other 
autoimmune diseases and could serve 
as a model for future drug research. 
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'High Quality, Zero Defects" 
In a candid interview, U H President J. 
Scott Abercrombie Jr., M.D., shares 
his views on such questions as: Is 
quality of care being compromised by 
the health-cost crunch? Is Boston 
really a medical mecca? Are hospi-
tals becoming too "bottom-line" 
oriented? Can universal health care 
work? 
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Keeping America Healthy At Work 
Occupational medicine is playing a 
major role in the health of the 
American worker. By working wi th 
business and industry, the U H Oc-
cupational Health Program has 
helped many employers realize that 
the cost of keeping their employees 
healthy at work is the most sound in-
vestment they can make. 
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Facing The Facts 
Even wi th a greater awareness, 
400,000 Americans w i l l be diagnosed 
w i t h some form of skin cancer this 
year. The U H Skin Oncology 
Program offers a ful l range of 
specialists to deal w i t h complex skin 
tumors and cancers. 
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News & Names 
In memory of Joseph Stokes 111, 
M.D....New appointments at the 
Hospital...UH people honored for 
achievements...A Gala Event...Staff 
members in the news. 
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when 27-year-old John McClay, a 
5-foot 11-inch, 230-pound body-
building champion, left the LA Fit-
ness Center in Rockland, Mass., to 
jog with a companion one warm 
February evening in 1985, little did 
he realize that the events to occur 
that night would change the course 
of his life. 
Fifty yards down the road, Mc-
Clay was hit from behind by an 
automobile being driven at 50 mph 
by a drunk driver, and he was 
thrown 40 feet over the guardrail. 
When paramedics arrived on 
the scene, McClay was lying uncon-
scious on the ground; his blood 
pressure was alarmingly low. A 
victim of multiple trauma, McClay 
suffered iniuries ranging from a 
closed head injury, broken back 
and a fractured pelvis, to a shat-
tered hip and knee, and a stomach 
and part of a leg buttock that were 
ripped open. Within minutes, a 
priest arrived on the scene to 
deliver last rites. 
McClay was rushed to South 
Shore Hospital in South 
Weymouth, where he was stabi-
lized, evaluated and then 
transported to the Boston Emergen-
cy Medical Center (BEMC), the 
joint trauma center of the Univer-
sity Hospital and Boston City 
Hospital, in the South End. 
When he arrived at BEMC, a 
highly skilled team of surgeons— 
consisting of a neurosurgeon, a 
trauma surgeon and an orthopedic 
surgeon—worked simultaneously 
and in unison for almost six hours 
to repair trauma to McClay's 
brain, abdomen, and a host of frac-
tures. He required 19 units of 
blood to compensate for the five to 
six liters he had lost since his acci-
dent. Following surgery, he was 
brought to the Surgical Intensive 
Care Unit at UH, only to return to 
the operating room several times 
for reconstructive surgery. 
Few people believed John Mc-
Clay would recover from his tragic 
accident to lead a vibrant life. 
That was four years ago. Today, 
McClay has seemingly beaten all 
odds. He is an A student at the 
Suffolk University Graduate 
School of Business, where he will 
obtain his master's degree in busi-
ness administration (MBA) next 
spring; he is looking for a manage-
ment position with a large firm. 
He also continues to work out four 
times a week at the gym, and he 
even serves as a judge for state 
amateur bodybuilding contests. 
BOSTON EMERGENCY 
MEOICAL CENTER 
Where UH and BCH trauma 
experts combine skill, timing and 
teamwork to save lives 
B Y C Y N T H I A L . P A R A D I S 
John McClay had been i n a coma for three months when he awoke i n a Univers i ty Hospital bed i n M a y 
of 1985. He s t i l l doesn't remem-
ber being h i t f r o m behind on Feb. 
22, 1985, nor does he remember 
the lifesaving efforts that allowed 
h i m to wake up again. 
" I ' m l u c k y to be alive," Mc-
Clay acknowledges, " A n d I feel 
the reason I am alive is because 
of the quick care I received the 
night of m y accident. But i f I 
wasn't such a fighter, I w o u l d n ' t 
have made i t this far. Some days 
1 wished I were dead, but then I 
te l l myself to 'hang i n there and 
be tough. '" 
His wife . Donna, w h o m he had 
married several months before 
the accident, is his best fr iend 
and biggest supporter. After 
spending 2 1/2 years i n four dif-
ferent hospitals f o l l o w i n g his acci-
dent, he returned to their home 
i n Weymouth , where he now 
moves about freely using a 
walker. 
McClay has become actively 
involved i n his rehabil i tat ion 
since his accident, w h i c h has left 
h i m permanently disabled f rom 
the waist down. He has returned 
to the L A Fitness Center, where 
he used to tra in six days a week, 
t w o hours a day, for state and na-
t ional body-building competi-
tions. [In 1981, McClay earned 
the t i t l e "Mr . N e w England" and 
he placed four th i n the "Mr . 
America" contest a year later.] 
Today, w h i l e his workouts are 
not nearly as intense and regi-
mented, they are an integral part 
of his rehabil i tat ion, consisting of 
l ight-weight , upper-body repeti-
t ive exercises. "If I quit , 1 may as 
w e l l be dead," he says. 
E r w i n F. Hirsch, M . D . , chief of 
the U H Trauma Section and the 
attending surgeon w h o supervised 
McClay's care that evening four 
years ago, recalls the extent and 
complexity of his injuries. "Basi-
cally, three operations were being 
• FOR YOUR INFORMATION 
Dr. Hirsch is 
director of 
Boston 
Emergency 
Medical Center 
(BEMC), chief 
of the U H 
Trauma Section, director of 
General Surgery at Boston City 
Hospital, and is an associate 
professor of surgery at Boston 
University School of Medicine. 
If you would like more 
information about BEMC, 
please call 1-800-842-3648. 
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conducted simultaneously, since 
his injuries were a l l life-threaten-
ing," he says. "Mr . McClay's 
s i tuat ion required major-league 
involvement of a variety of surgi-
cal specialists. We did what we 
could i n a t imely , expert fashion, 
but luck also was on his side." 
U H neurosurgeon Joe Ordia, 
M . D . , and orthopedic surgeon 
Isadore G. Yablon, M . D . , worked 
w i t h Hirsch that evening. 
A deadly epidemic 
Trauma is an epidemic,- i n fact, i t 
is the leading cause of death 
among people under age 44. A n 
estimated 140,000 Americans die 
each year f r o m trauma and more 
than 300,000 others are per-
manent ly disabled as the result of 
traumatic in jury . 
Recognizing that prompt and 
ski l led care can mean the dif-
ference between life and death, or 
between a f u l l recovery or per-
manent disabil i ty, U H and Bos-
t o n C i t y Hospital have joined for-
ces to provide high quali ty, i n -
novative trauma care. Together, 
U H and B C H f o r m a trauma cen-
ter k n o w n as Boston Emergency 
Medical Center (BEMC), one of 
three designated Level I trauma 
centers i n Metropol i tan Boston. 
Most often, trauma patients 
are stabilized i n the B C H emer-
gency room—one of the highest 
vo lume ERs i n the country—and 
then receive their specialized care 
at U H . W i t h such strengths as 
M e d Flight, a medical emergency 
helicopter, and helipad facilities 
for quick access, the trauma cen-
ter can treat patients w i t h l ife-
threatening injuries at a 
moment 's notice. 
More than 1,200 trauma 
patients are brought annually to 
BEMC, where appropriate staff-
ing, expertise, service and tech-
nology are available 24 hours a 
day. Patients whose conditions 
are too severe or complex for 
emergency rooms i n other Mas-
sachusetts hospitals or hospitals 
Mary Howard Scott: Airlifted to safety 
Mary Howard Scott, 41, of Ken-
nett Square, Pa., was vacationing 
on Nantucket this past summer 
when she suffered severe head 
trauma after falling from her 
bicycle. Within four hours of her 
accident, Scott was undergoing 
emergency surgery at the Univer-
sity Hospital in Boston for a 
skull fracture and a subsequent 
blood clot on the surface of her 
brain, which would have killed 
her had she not been given 
prompt care. 
Scott was initially rushed in a 
coma to Nantucket's 
Cottage Hospital, where 
i t was determined that 
she needed the facilities 
that only a trauma cen-
ter could provide. Short-
ly thereafter, she was air-
lifted to BEMC via Bos-
ton MedFlight, an emer-
gency medical helicop-
ter that has proven over 
the past several years to 
be a key to immediate 
and efficient care for 
many trauma patients. 
"Mrs. Scott's injuries 
were life-threatening 
and could have caused 
either a stroke or death 
had she not received 
prompt attention," says 
Scott's attending 
physician at UH, Ed-
ward Fischer, M.D., a 
neurologic critical care 
specialist. 
The care that Scott was given 
allowed her to leave the Univer-
sity Hospital one week after her 
accident—an incredibly short 
hospitalization for a trauma 
patient, Fischer says. A ful l 
recovery is expected. 
"Without the helicopter, i t 
would have taken closer to 10 
hours to get care to Mrs. Scott," 
says Terence G. Dougherty, ad-
ministrative director of Boston 
MedFlight. "The only other alter-
native would have been a ferry and 
i n nearby states are brought to 
the eenter, either directly or after 
being given i n i t i a l care else-
where. 
The two Ts: trauma, teamwork 
The Boston Emergency Medical 
Center is an integrated system. 
"Trauma care requires a team of 
professionals who understand al l 
aspects of quick, responsive 
medicine," says Hirsch, the direc-
tor of BEMC and the director of 
General Surgery at Boston C i t y 
Hospital . "A surgeon alone, i n 
any type of trauma case, w i l l 
never be the sole determinant of 
success or failure. There must be 
the presence of other staff—count-
less others—to care for a patient 
effectively." 
The best outcomes for trauma 
v ic t ims rests on several key fac-
tors, Hirsch says: 
• The promptness w i t h w h i c h 
the care is administered, 
• the capabilities, qualifications 
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that, alone, wouki 
have taken 3 1/2 
hours, if it were in 
port." 
Airlifting patients 
to safety 
The University 
Hospital, which 
played the leading 
role in developing 
MedFlight, is part of 
a consortium of 
Boston's academic medical 
centers operating the 24-hour-a-
day, seven-day-a-week service. 
Since airlifting its first patient on 
June 25, 1985, Boston MedFlight 
has transported more than 2,000 
critically injured and critically i l l 
patients to Boston medical 
centers. Last year, Boston Med-
Flight airlifted nearly 700 
patients, 115 of whom were 
iDrought to BEMC. Most Med-
Flight missions are to transfer 
acutely i l l patients from a subur-
ban hospital to one of the Boston 
trauma centers. 
Boston MedFlight is staffed by 
a critical care nurse trained in 
emergency medicine, a 
paramedic and a pilot. The nurse 
and paramedic work hand-in-
glove unti l a patient is safely on 
the ground and hospital trauma 
personnel can take over the 
patient's care. 
A virtual "ambulance in the 
air," Boston MedFlight must 
meet all the requirements of an 
advanced life-support ground am-
bulance with regards to staff and 
equipment. Suzanne K. Wedel, 
M.D., a surgical critical care 
specialist in the intensive care 
units at both UH and BCH, says 
there are two advantages to using 
a helicopter in the care of trauma 
patients. "One is obviously 
speed; we can especially ap-
preciate that, being in Boston 
with all its traffic congestion. 
The other advantage," she says, 
"is the impact of the helicopter 
medical team in beginning early 
resuscitation or stabilization. 
[The team I acts as an extension 
of the tertiary center emergency 
room or intensive care unit. It 
can bring tertiary care to patients 
quicker." 
and expertise of the trauma 
team, 
• and the magnitude of the i n -
jury. 
"The [people involved] i n a 
patient's care should be so 
famil iar w i t h what has happened 
to the person that he or she can 
program a recovery phase, look 
for potential eomplieations and 
deal w i t h t h e m before they be-
come an issue," Hirsch con-
tinues. "That's part of the team 
effort—that everyone th inks i n 
that direction together." 
Even w h e n al l of these require-
ments are present, however, 
trauma care includes a b i t of luck. 
N o matter how prompt and 
ski l led the care delivered to a 
patient may be, Hirsch says, 
"Sometimes, given the best ef-
forts, things don't go w e l l . 
Trauma has many different ways 
of presenting itself; this is not a 
predictable w o r l d . " For example, 
a 58-year-old male, the v i c t i m of 
a t ra in accident, was air l i f ted 2 
1/2 hours to Boston C i t y Hospital 
f r o m a Maine t o w n on the 
Canada/U.S. border and under-
went eight hours of surgery, only 
to die the fo l lowing night of a 
heart attack. 
The dynamics of trauma 
Hirsch is one of six academic 
trauma surgeons responsible for 
the admission and overall coor-
dinat ion of care for a trauma 
patient. The others are Desmond 
H . Birkett , M . D . , Garry E. 
Fitzpatrick, M . D . , Jonathan Wood-
son, M . D . , Gene A. Grindlinger, 
M . D . and Riad Cachicho, M . D . 
"Each is tota l ly qualified to 
manage, coordinate and ad-
minister the care of trauma 
patients," Hirsch says. 
Hirsch explains that trauma is 
divided in to t w o categories— 
blunt or penetrating. Ap-
proximately 45 percent of 
BEMC's trauma patients are vic-
t ims of "blunt" trauma; that is, 
trauma that is caused by v i r t u a l l y 
any type of accident, such as an 
automobile or motorcycle acci-
dent. The remaining 55 percent 
of the Center's trauma patients 
are v ic t ims of "penetrating" 
trauma, or trauma f rom a gun-
shot or stab wound. 
From the t ime a trauma 
patient is brought to the doorstep 
of BEMC to the t ime he or she is 
rehabilitated, the patient is given 
the tools needed to return to 
society. 
"The end product of trauma 
care, i f the outcome is good, is a 
total ly rehabilitated, normal 
funct ioning person and that's part 
of the philosophy of trauma 
care," Hirsch says. 
About some of his former 
patients, he notes, "They are real-
ly super people. It's unbelievable 
what a wel l -motivated, success-
f u l l y rehabilitated patient can 
do." 
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'High Quality, Zero Defects' 
A conversation with J. Scott Abercrombie Jr., M.D. 
J. Scott Abercrombie Jr., M.D., bas been 
tbe President of the University Hospital 
since 1980. During his tenure, Abercrombie 
has guided UH through years of prosperity 
and physical change, and is now steering 
the Hospital through a period of unprece-
dented challenges facing all hospitals, and 
teaching hospitals in particular. In an inter-
view with Progress editor Mike Paskavitz, 
Abercrombie shares his views on health 
care at UH, in Massachusetts and 
throughout the country. 
QMA 
Progress: It has become clear that 
hospitals in Massachusetts have 
reached the crisis stage in their finan-
cial health. Why has this happened 
so quickly? 
Abercrombie: The biggest single 
reason that hospitals are suddenly 
faced with financial difficulty is that 
the federal government has severely 
restricted Medicare payments. Hospi-
tals in Massachusetts are now 100 
percent under the national Medicare 
prospective payment system, which 
pays the same for a procedure in a 
Hawaii hospital as it does in a Mas-
sachusetts hospital, despite special 
circumstances or complications, or 
the relative costs of caring for the 
patient. Health care in this state has 
been more expensive than in most 
states, and we are now at the point 
where each Medicare patient costs us 
more than we are paid, whereas some-
where else in the country where the 
cost of caring for a patient is under 
the average Medicare payment, those 
hospitals are doing all right. 
In other states where health care is 
as expensive as it is in Massachu-
setts, they can shift their costs to 
other payers in order to not absorb a 
loss from caring for a Medicare 
patient. However, hospitals in this 
state are prohibited by law from shift-
ing costs. The Massachusetts Rate 
Setting Commission sets revenue 
limits for us, so if we in Massachu-
setts lose money on Medicare, we 
cannot make it up through private 
payers. 
Now, if you have all of this, plus a 
governor and state legislature who 
don't pay their bills (in particular. 
Medicaid, which represents 11 per-
cent of UH's budget), then that just 
adds to the problem. 
Progress: Wouldn't hospitals in Mas-
sachusetts, which is considered a 
medical mecca, receive some sort of 
special consideration? 
Abercrombie: I do not believe that 
Boston is quite the medical mecca i t 
thinks it is. I think that the "mecca" 
changed after World War I I , when the 
government began to distribute 
money differently. There is no longer 
a stronghold in medicine among the 
East Coast cities; there is more parity 
around the country. Stanford, for ex-
ample, is the leading institution for 
heart transplants in the world; it's 
not in Boston. So a mecca is where 
the doctors and resources are. If Dr. 
[Norman] Shumway (a pioneer in 
heart transplantation at Stanford) 
were in Little Rock, Arkansas, that's 
where the mecca for heart transplants 
would be. I do think that Boston still 
has the highest concentration of 
medical talent, because it's so small. 
And that isn't likely to change. 
Progress: Are hospitals being forced 
to run more like traditional busi-
nesses, and is there a danger that 
quality of care might be com-
promised? 
Abercrombie: I don't think that wor-
rying about the bottom line necessari-
ly implies a threat to quality of care. 
No matter how you look at it , hospi-
tals have to aim at breaking even. 
It's a whole lot easier to provide 
quality when you're breaking even 
than when you're struggling to sur-
vive. 
But I do think hospitals could be 
squeezed enough so that it could chal-
lenge the quality of care. To look at 
it from another perspective, the 
people who get no care in this 
country have poor health, so that too 
is considered poor quality. 
In my view, the challenge in think-
ing about quality of care is to break 
away from thinking that there's only 
one way to provide quality. One 
should never believe that there is 
only one way for things to be done. I 
believe that we might be able to do 
things in a different way and deliver 
the same high quality care for less 
cost. We are now exploring what 
some of the alternatives are. 
Progress: You've used the theme 
"High Quality, Zero Defects" to 
describe the University Hospital's ap-
proach to change. What does that 
mean? 
Abercrombie: Let me premise this by 
saying that our approach is driven by 
what we call our Change Project. In 
my view, there are no gimmicks to 
this dilemma. It costs us more to 
care for patients than what we are 
paid for. Even if we increase our 
volume, we must reduce our costs. 
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The theme, "High Quality, Zero 
Defects," is not a perfect one, but i t is 
appropriate. It relates to the prin-
ciples of cost and quality. I think one 
should ask oneself why Honda 
owners have a 98 percent satisfaction 
rate, meaning that they would buy a 
Honda again. Why is that? That 
number is higher than for Mercedes 
Benz or Rolls Royce. Qn the other 
hand, why are the retention numbers 
for American car buyers, even the Lin-
coln, not nearly as high? I 'm not ex-
actly sure why, but I personally 
believe that it's because people w i l l 
respect, and w i l l even pay a premium 
for, quality. For what you pay for a 
Honda, you can get an American car 
that is one and a half times larger. 
Yet people choose to pay the 
premium for quality. 
Even if we are the best, we can he 
better. The Trump Shuttle says i t 
leaves the gate at 7:00, not 7:01. Qb-
viously hospitals have many more 
variables in delivering quality patient 
care, but we do have to find ways of 
ensuring efficiency. 
Progress: Does the University 
Hospital's respect for business prin-
ciples extend to restructuring its ser-
vices along "product lines," like so 
many hospitals have? 
Abercrombie: Qurs is certainly not 
what I think classic product-line 
management is, but we are moving in 
a direction where part of our struc-
ture is set up in a similar way to 
product-line management. The trend 
is to have managers responsible for 
certain groupings of related services. 
A very good recent article by Jeff 
Goldsmith [Harvard Business 
Review, May/June 1989] talked about 
such issues. I was particularly in 
agreement w i t h what was said about 
hospitals who have relied on retail 
strategies, such as merchandising, 
brand names and media campaigns, 
being casualties of this decade. Many 
hospitals tried to f i l l beds through 
marketing, while not concerning 
themselves wi th operating efficiency. 
Also, what some strategies did was 
create systems that alienated the doc-
tor from the patient. There is a 
sacredness to the doctor-patient 
relationship that should not he under-
mined by systems. Here at UH, as 
best we can, we are intending to wed 
the operations-driven management 
style w i t h the marketing-driven 
style. I really think you have to do i t 
that way. Quality of service is far 
more critical than organizational 
design, and that's the way we're ap-
proaching our Change Project. 
Progress: The Massachusetts Univer-
sal Health Law (Chapter 23), which 
calls for increased government invol-
vement in assuring access to health 
services, is said to be highly flawed, 
so is the prospect of universal health 
insurance unrealistic? 
'There are so 
many people 
l iving i n the 
streets of this 
country, yet 
we demand 
the very best 
medical care' 
Abercrombie: First of all, how do we 
know whether Chapter 23 is dis-
astrous, since i t has hardly been put 
into place. It may, indeed, prove to 
be disastrous because i t hasn't been 
funded properly, and i t puts a great 
burden on small businesses. 
The problem with universal health 
schemes—whether local, state or na-
tional—is funding. Who w i l l pay for 
it? 1 would grant that those who con-
ceive these plans are interested in ac-
cess to care, but they haven't figured 
out a way to pay for i t . And if they 
believe that health care can be 
delivered more cheaply on a state or 
national scale, they're mistaken. 
Right now, no one is paying for the 
health care of 39 mill ion Americans. 
Isn't i t awful that so many Americans 
can't receive care? But another ques-
tion is: what w i l l happen if you add 
to an already flawed system another 
39 mill ion people who aren't even 
paying right now? The cost of provid-
ing just basic health care would he 
staggering. The funding issue is 
usually the last thing to he dealt wi th 
by those who propose such plans. 
Some would argue that we in this 
country already pay enough for 
health care, but that it's not dis-
tributed properly. If that's so, then 
why not deal wi th that first, rather 
than figuring out a way to bring 
everybody into a flawed system? 
I also don't like anything that con-
siders health care in Alaska to be the 
same as i t is in Arkansas; i t is bound 
to he wrong. That's part of the 
trouble wi th Medicare: i t considers 
the health care needs of the Eskimos 
in Alaska the same as the needs of 
farmers in Arkansas. What is not un-
derstood is that Tip Q'Neil's (former 
Speaker of the U.S. House of 
Representatives) statement about 
politics ('all politics is local') applies 
to health care as well—it is very 
local. Health care is not the same in 
Chelsea as i t is in Milton. 
Here's a radical thought for a 
hospital CEQ: medical care may be 
viewed as more important than i t 
should be. Food and housing are cer-
tainly more important. Running 
water is more important. In some 
I cases, garbage collection may be 
more important. While we see a 
great number of people living in the 
streets of this country, we all demand 
the best medical care. I 'm not saying 
I'm opposed to an all-encompassing 
system, but there would be a lot to 
talk about and there may be more im-
portant problems to address first. 
Progress: What is your outlook for 
U H as we enter the next decade? 
Abercrombie: It would be my objec-
tive to have U H emerge stronger, rela-
tive to other hospitals. It may he 
that all hospitals w i l l he in poorer 
shape in five years than they are now. 
But I expect us to persevere. We have 
a strong medical school whose stat-
ure is becoming more clearly acknow-
ledged in the Commonwealth. We 
have a bright and committed medical 
staff. 1 also think we have many fine 
young, dedicated managers wi th 
ideas. That gives me a strong sense 
of optimism. But i t all comes back to 
quality; we have to he both efficient 
and good. 
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An employee at a major 
metropolitan newspaper, who 
uses chemical solvents in his 
hands-on pressroom work, is af-
flicted with numbness and tin-
gling in his fingers and hands. 
Several workers at a styrofoam 
plant experience symptoms of im-
potence and urinary problems 
that are traced to a chemical 
used in the manufacturing 
process. 
These cases typi fy the work-re-
lated problems seen by the 
Univers i ty Hospital's Occupation-
al Health Program (OHP), the 
only such f u l l - t i m e , full-service 
program i n Boston, and one of 
only 25 i n the country w i t h a 
residency tra ining program. The 
OHP's involvement i n workplace 
illnesses has grown dramatically 
i n recent years, reflecting what ap-
pears to be a major recognition of 
occupational health by industry 
and business. 
As recently as 15 years ago, the 
relationship between medicine 
and industry was less than har-
monious. Today, however, i t is 
becoming apparent that keeping 
employees healthy, f i t and produc-
t ive is the most sound invest-
ment a business can make. 
Employers now f i n d i t practical 
to hire physicians to evaluate 
their w o r k sites and their 
employees for health risks. 
Robert J. McCunney, M . D . , 
c l inical director of the OHP, says, 
"We believe that people should 
not compromise their health be-
cause of work , and that point of 
view is now being embraced by 
workers, employers, unions and 
legislators." 
Occupational medicine dates 
back to the 17th century, w h e n 
Ital ian physician Bernardino 
Ramazzini, the "Father of Occupa-
t ional Medicine," studied the 
health problems of laborers. \
Perhaps the most w e l l - k n o w n 
occupational health problem was 
the rampant sickness among 
workers i n the Chicago meat-
packing industry around the t u r n 
of the 19th century (chronicled i n 
U p t o n Sinclair's landmark novel, 
"The Jungle"). 
Such w o r k i n g conditions do 
not exist today, i n a era of r ig id 
state and federal occupational 
health and safety laws and space-
age technology, but people s t i l l 
get sick or hur t at w o r k . Despite 
al l the laws and safety advance-
ments, some 100,000 Americans 
die each year f rom occupation-
related illnesses, twice 
the number that die 
annually i n auto 
accidents. Most ex-
perts feel that this n u m -
ber is grossly underes-
t imated, since many deaths are 
not traced back to possible con-
t r ibutory factors. 
The Univers i ty Hospital's i n -
volvement i n occupational 
medicine began i n the 1950s, 
when pulmonary specialist Ed-
ward Gaensler, M . D . , helped to 
pioneer research i n asbestos-re-
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lated lung disease. This leader-
ship, and the expertise i n occupa-
t ional neurology of current OHP 
medical director and U H chief of 
neurology, Dr . Robert G. Feldman, 
formed a f i r m foundation for 
today's program. 
According to Feldman, the U H 
program serves three pr imary pur-
poses: to provide c l inical services 
to diagnose and treat work-re-
lated illness or in jury; to educate 
physicians, workers and 
employers about oc-
cupational r isk factors 
and preventive 
measures; and to per-
f o r m research in to the 
causes and effects of oc-
cupational illness and 
in jury . This tr iple mis-
sion is the heart and soul of 
American teaching hospitals, 
where major resources can be 
brought to bear on a pervasive 
health problem. 
"The [OHP] is a conduit for a 
medical center, a point of entry 
in to the health care system," 
says Feldman. A m u l t i d i s c i p l i -
nary medical center is an ideal 
setting for such a program, 
since many c l inical 
services, such as i n -
ternal medicine, radiology, der-
matology, orthopedic surgery, 
physical therapy, cardiac 
rehabil i tat ion, pulmonary 
medicine, and neurology, are 
often required. 
The format ion of the Occupa-
t ional Safety and Heal th A d -
m i n i s t r a t i o n (OSHA) and the Na-
t ional Inst i tute for Occupational 
Safety and Heal th (NIOSH) have 
"advanced the f ie ld and earned 
greater respect f rom the medical 
c o m m u n i t y , the legislature and 
business leaders," says Feldman. 
N i n e t y percent of American 
companies have fewer than 100 
employees and few have in-house 
occupational health programs. 
But i t is the major corporations 
who have realized the long-term 
benefits of having healthy 
employees. The OHP has a client 
l is t that includes the Boston 
Police and Fire Departments, 
Northwest Air l ines , the D i g i t a l 
and Teradyne corporations, and 
other business leaders. 
Prevention throngh research 
Occupational health has an 
epidemiological focus: For many 
patients, treatment is available 
for a work-related in jury or i l l -
ness, but as Feldman points out, 
"Most times, the damage has al-
ready been done. We are as con-
cerned about the research value 
of indiv idual cases as we are 
about treating each case, because 
we can learn something f r o m the 
indiv idual case that can lead to 
preventive measures," he says. 
For example, several top 
workers at the Sprague Flectric 
Gompany i n Sanford, Maine, suf-
fered f r o m carpal tunnel 
syndrome—a condit ion where 
constant wris t movement causes 
nerve damage to the hand and 
arm. By w o r k i n g w i t h the OHP, 
the company discovered that the 
conditions were caused by the 
design of their machinery. A 
resulting design protected workers 
f r o m further in jury and saved the 
company considerable 
SOME HAZARDS IN THE WORKPLACE 
In 1983, NIOSH published its list of the ten leading work-related diseases 
and injuries (the accompanying conditions and examples are merely 
selected samples; they are not comprehensive, categorical definitions): 
1. Occupational lung disease— 
such conditions as asbestosis, 
silicosis, coal workers' 
pheumoconiosis, lung cancer and 
occupational asthma. EXAMPLE: 
Each year, an estimated 65,000 
Americans develop a work-related 
respiratory disease, and about 
25,000 deaths are attributed to oc-
cupational lung disease annually. 
Although typically associated wi th 
miners, laborers and chemical 
workers, this affliction has also 
been found in certain office 
workers. Most indoor illnesses are 
associated wi th chemically con-
taminated air ventilation systems. 
2. Musculoskeletal injuries—in-
eluding disorders of the back, 
trunk, upper extremity, neck, 
lower extremity; traumatieally in-
duced Raynaud's disease. 
EXAMPLE: Those who work at 
video display terminals (VDTs) are 
considered at risk for visual 
problems brought on by eye strain 
and for "ergonomic" injury—back, 
shoulder or neck injuries from sit-
ting in a poorly designed chair. 
3. Occupational cancers (non-pul-
monary)—such diseases as 
leukemia; mesothelioma; cancers 
of the bladder, nose and liver. 
EXAMPLE: Many chemical agents 
and pollutants carry a long-term 
risk for cancer. Bladder cancer has 
been found in industrial laborers 
who work regularly with 4-
aminobiphenyl, Auramine, Ben-
zidine and 2-naphthylamine. 
4. Severe occupational traumatic 
injuries—such as amputations, frac-
tures, eye loss, lacerations and 
traumatic deaths. EXAMPLE: 
Many laborers and workers, such 
as those who work w i t h heavy 
equipment, are at risk for 
traumatic injury. 
5. Occupational cardiovascular dis-
eases—such conditions as hyperten-
sion, coronary artery disease and 
acute myocardial infarction. 
EXAMPLE: Carbon monoxide, the 
chemical emissions from auto-
mobile engines, causes drowsiness 
and headaches, but studies in Los 
Angeles also linked carbon mono-
xide to an increase in emergency 
room cases of anginal chest pain. 
6. Reproductive disorders—such 
conditions as impotence, infer-
t i l i ty , spontaneous abortion and 
developmental abnormalities in 
fetuses. EXAMPLE: The agent 
dibrimo-3-cloropropane, used by 
pesticide production workers, has 
been linked to sterility and im-
potence; and lead is considered a 
risk factor for miscarriage, birth 
defects and male infertility. 
7. Neurotoxic disorders—such con-
ditions as peripheral neuropathy, 
toxic encephalitis, psychoses, ex-
treme personality changes (ex-
posure-related). EXAMPLE: Nearly 
200 of the more than 60,000 chemi-
cals manufactured or used in the 
U.S. could be listed as carcinogens; 
another 2,000 are potential car-
cinogens. Long-term contact w i t h 
harmful solvents and chemicals 
could cause neurologic damage, 
lung disease, cancer, diseases of the 
vital organs, birth defects and 
genetic changes. 
8. Noice-iuduced hearing loss—Of 
the 105 mill ion workers in the 
U.S., OSHA estimates that almost 
14.5 mil l ion workers are exposed to 
noise levels loud enough to lead to 
short- and long-term hearing loss. 
Damage from noise exposure 
begins at 75 decibels, about the 
noise level of traffic at a major in-
tersection. The standard for a work 
environment is 90 decibels. 
9. Dermatoiogic conditions—such 
conditions as dermatoses, scalding 
burns, chemical burns and con-
tusions and abrasions. EXAMPLE: 
Contact dermatitis, an inflamma-
tion of the skin, is caused by nickel 
and rubber compounds,- and those 
who work in cold temperatures are 
also vulnerable to skin conditions, 
such as Raynaud's disease. 
10. Psychologic disorders—such 
conditions as neuroses, personality 
disorders, and substance abuse. EX-
AMPLE: Stress is a common bypro-
duct of many jobs; a bored assemb-
ly line worker may suffer stress 
levels equal to that of a stock-
broker. Stress has been associated 
wi th substance abuse, and also has 
been shown to contribute to hyper-
tension, a major risk factor for 
coronary heart disease. 
health, disabil i ty and workers ' 
compensation costs. 
M a n y corporations are expand-
ing their occupational health 
programs to include "wellness" 
programs, w h i c h can involve 
n u t r i t i o n counseling, weight con-
t ro l , smoking cessation, blood 
pressure and cholesterol screen-
ings, and stress management. 
W i t h the recent passing of the 
federal D r u g Free Workplace Act , 
the OHP has begun to provide as-
sistance to companies i n develop-
ing drug policies, performing test-
ing and evaluating specimens. 
Another key element is evalua-
t i o n . Feldman and McCunney 
spend a great deal of t ime inves-
t igating whether a disease is work-
related and whether a job task is 
responsible. For instance, i f a 
worker has a pulmonary disorder, 
is i t due to exposure to chemical 
toxins at w o r k or the result of a 
chronic smoking habit? The con-
clusions have major ramifications. 
Michael R. Paskavitz 
FOR YOUR INFORMATION 
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IK Classical 
Strategy 
To Defeat 
Cancer 
An innovative 
'designed drug 
that kills 
leukemia cells 
may have 
other exciting 
possibilities 
r he struggle against cancer has tradit ional-l y been l ikened to a war. The classic tale of the Trojan Horse— 
w h i c h , pul led inside the c i ty 
walls of ancient Troy, was found 
to be f i l l ed w i t h conquering 
Greek soldiers—has a modern-
day counterpart. A new drug 
under study at the Univers i ty 
Hospi ta l has been described as a 
Trojan-Horse approach to cancer 
treatment because i t appears as a 
"friendly" protein to certain can-
cer cells, yet i t carries w i t h i n its 
structure a deadly t o x i n . 
After several years of intensive 
research at U H , this unique drug, 
k n o w n as IL-2 tox in , is now being 
used i n patient trials at U H and 
the M . D . Anderson Cancer 
Center i n Houston, Texas. These 
cl inical trials w i l l test the new 
genetically designed drug, w h i c h 
attacks and k i l l s malignant can-
cer cells i n patients afflicted w i t h 
certain leukemias or lymphomas. 
The drug is the result of the 
genetic fusion of t w o separate 
natural proteins—interleukin-2 
and diphtheria t o x i n — t o create a 
hybr id protein. 
"IL-2 t o x i n is the f irst 
'designer' biological drug," says 
John R. M u r p h y , Ph.D., chief of 
Biomolecular Medicine at U H 
and creator of the drug. " I t is an 
absolutely novel approach that 
combined t w o separate natural 
proteins to create a t h i r d protein." 
The drug, w h i c h is produced 
by the biotechnology f i r m 
Seragen, Inc., is absorbed by l y m -
phoma or leukemia cells that 
have receptors for the inter leukin-
2 por t ion of the molecule,- inter-
leukin-2 is a growth factor or 
"nutr ient" for certain cancer cells. 
Because the cancer cell recog-
nizes interleukin-2 as "food," i t al-
lows the IL-2 t o x i n to enter the 
cell. Once inside the cell, the 
diphtheria t o x i n por t ion of the 
protein separates itself f r o m the 
IL-2, and attacks and k i l l s the can-
cer cells. 
This innovative research rivals 
a parallel approach to cancer 
therapy w h i c h employs drugs 
k n o w n as immunotox ins . These 
drugs, w h i c h are formed by at-
taching a t o x i n to an antibody, 
b ind themselves to cancer cells 
but often are unable to actually 
get inside the cell the way IL-2 
does. Because the antibody i n the 
i m m u n o t o x i n is unable to enter 
the cell, at t imes a large dose of 
radioactive material must be at-
tached to the antibody for i t to 
k i l l cancer cells. A n d because 
the doses required are so large, 
i m m u n o t o x i n s also harm healthy 
cells. 
Studying IL-2's effectiveness 
The cl inical study at U H , headed 
by Chief of Medical Oncology 
Ronald P. McCaffrey, M . D . , w i l l 
involve 30 patients afflicted w i t h 
cancers of the blood and l y m p h -
forming system. According to 
McCaffrey, the criteria for 
patients entering the study are 
that "their condit ion has failed to 
respond to standard therapy, and 
their diseased cells have recep-
tors for IL-2." 
A l t h o u g h the IL-2 receptor was 
first thought to be found only on 
cells f r o m adult T-cel l leukemia 
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How IL-2 Toxin Works 
Si Antibodies ^ 
Immunotoxicology 
The above illustration shows how IL-2 toxin enters an IL-2 receptor-positive cancer cell 
and kills the cell. The drawing at hottom left illnstrates how immnnotoxins—a parallel ap-
proach to cancer therapy—are unable to penetrate the cancer cell's structure. 
(ATL), i t now is k n o w n to be 
present on several kinds of 
leukemias and lymphomas. "We 
w i l l focus p r i m a r i l y on chronic 
lymphocyt ic leukemia (CLL) i n 
the beginning of the study, but 
also w i l l involve appropriate A T L 
patients," McCaffrey says. 
Chronic lymphocyt ic 
leukemia, the most c o m m o n 
f o r m of leukemia i n the Western 
Hemisphere, is most often found 
i n older patients, w h o range i n 
age f r o m 40 to 70. CLL, w h i c h 
sometimes doesn't present 
symptoms early on, develops 
w h e n defective w h i t e blood cells 
replicate and decrease the produc-
t i o n of protective antibodies, 
w h i c h makes the patient v u l -
nerable to infection, and eventual-
ly may invade bone marrow and 
various organs. Tradi t ional 
therapies for CLL include 
chemotherapy, steroids and 
radiotherapy; most patients sur-
vive for five to 10 years being 
treated w i t h these therapies. 
A d u l t T-cel l leukemia is a 
deadly disease w i t h no current 
therapeutic intervention; i n acute 
phases, many patients die w i t h i n 
five months of diagnosis. 
Physicians concerned about the 
morb id i ty of the disease are equal-
l y concerned about the threat of 
transmission, since A T L is as-
sociated w i t h the retrovirus 
H T L V - 1 and has the same f o r m 
of transmission as the AIDS 
virus. This type of leukemia is 
most prevalent i n southern Japan, 
Africa, and the Caribbean, but 
also has been seen w i t h increas-
ing frequency i n needle-sharing 
drug addicts i n N e w York, N e w 
Orleans and Newark, N e w Jersey. 
McCaffrey says that patients i n 
the study w i l l f irst be admini -
stered the drug and then w i l l be 
observed for several weeks to 
measure its benefit. If the drug 
proves effective, the patients w i l l 
continue on the therapy u n t i l 
they reach "a m a x i m a l l y 
tolerated dose or m a x i m a l l y effec-
t ive dose," he adds. " A n d al-
though i t is not part of the FDA-
approved study, we also w i l l be 
looking separately at whether a 
patient's cells are sensitive to the 
t o x i n i n the laboratory." 
"We're going to learn an awful 
lo t f r o m these c l inical trials. I n 
addit ion to levels of safety and 
tolerabil i ty, we w i l l learn a great 
deal about the pharmacokinetics 
and pharmacodynamics of this 
molecule," says M u r p h y . "This 
w i l l a l low us to go back to the 
drawing board and further refine 
the drug. If you were to ask 'can 
we make i t better?,' the answer 
w i l l almost certainly be yes. I 
w o u l d be extremely surprised if 
this prototype of IL-2 t o x i n were 
the best agent." But because of 
the new-found abi l i ty of scien-
tists l ike M u r p h y to genetically 
design drugs, IL-2 t o x i n should 
evolve in to a c l in ical ly useful 
agent more quick ly than tradi-
t ional therapies. 
A novel approacti to researcli 
"This hybr id protein is most cer-
ta inly the start of this type of re-
search; that is, research that sets 
out to design new therapies for 
specific purposes," says M u r p h y . 
The IL-2 t o x i n is the result of 
innovative genetic engineering 
techniques performed by M u r p h y 
and his colleagues, part icularly 
Terry Strom, M . D . , director of 
Cl in ica l Immunology at Beth Is-
rael Hospital i n Boston. 
M u r p h y notes that ap-
proximately 800,000 agents have 
been tested as potential cancer 
therapies, and of that number, 
only about 40 agents are available 
on the market today. What is i n -
teresting about the IL-2 t o x i n is 
that w h i l e most cancer therapies 
are tested because of a promising, 
and often accidental, discovery i n 
a laboratory, "the IL-2 t o x i n is the 
first drug to enter c l inical trials 
that was specifically designed 
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and engineered to perform a par-
ticular task," he adds. 
Most drugs go through several 
stages of investigation, i n w h i c h 
derivatives of the original drug 
are developed and tested i n pur-
suit of a f inal , refined commercial 
product. "The beauty of this 
study is that we knew f r o m the 
beginning what diseases i t w o u l d 
be tested for," says McCaffrey. 
"Most experimental cancer 
therapies are non-specific and 
need to be tested against nearly 
every f o r m of cancer." 
I n addit ion to its potential 
TL-2 is the 
::irst drug 
tested i n 
patients that 
was designed 
for a particular 
task' 
benefit against leukemia and l y m -
phoma, IL-2 t o x i n also has shown 
great promise i n several other 
areas, especially i n autoimmune 
disease. "There are a number of 
auto immune diseases i n w h i c h T-
cells w i t h IL-2 receptors play a 
major role," M u r p h y points out. 
"For example, i n the case of 
diabetes, rheumatoid arthrit is , 
m u l t i p l e sclerosis and myas-
thenia gravis, i t could be that IL-
2 tox in , or perhaps a derivative of 
i t , could play a therapeutic role." 
Another area that could 
benefit f r o m IL-2 t o x i n is acute 
graft rejection i n patients w i t h 
n e w l y transplanted kidneys, 
hearts, l ivers and other organs. I n 
fact, before IL-2 receptors were 
found i n certain cancer cells. M u r -
phy and Strom were directing 
their research toward graft 
transplants. 
But M u r p h y cautions that the 
more immediate application may 
he i n the area of auto immune dis-
ease. "That is not to say that the 
IL-2 t o x i n w i l l not he helpful i n 
graft transplantation, hut acute 
graft rejection tends to have very 
dramatic T-cel l mediated reac-
tions, w h i l e auto immune dis-
eases have a smoldering reaction 
that may he more conducive to IL-
2's therapeutic effect." 
"The concept of [Dr.] Murphy 's 
research, taking a cancer cell's 
nutr ients—its growth factor—and 
l i n k i n g i t to a tox in , can he ap-
plied to a wide range of cancers 
and other diseases," McCaffrey 
points out. "For example, there is 
a growth factor i n lung cancer, 
k n o w n as homhesin, that we 
t h i n k could he useful i n directing 
a t o x i n to lung cancer cells. I t is 
very exciting, rational research." 
As a measure of the h igh 
quali ty of this biomolecular re-
search, the Nat iona l Cancer In-
st i tute (NCI) has awarded a re-
search grant to establish a N a t i o n -
al Cooperative Drug Develop-
ment Group, consisting of M u r -
phy, Strom, McCaffrey, Vickie 
Kelley, Ph.D., of Brigham and 
Women's Hospital , and repre-
sentatives f r o m the N C I and 
Seragen, Inc. This group, one of 
nine drug development groups 
throughout the U.S., w i l l further 
IL-2 t o x i n research w i t h the hope 
of advancing its c l inical introduc-
t i o n more quickly . 
Bringing research to the bedside 
W i t h the recent opening of the 
Hospital 's new biomolecular 
medicine laboratory, a state-of-
the-art fac i l i ty has been made 
available for advanced 
biomolecular research. Because 
most biomolecular laboratories 
are located i n basic science 
facilities or i n research i n s t i t u -
tions, interact ion among scien-
tists, physicians and patients 
tends to he l i m i t e d . 
"This laboratory w i l l a l low for 
a more natural interact ion be-
tween basic research scientists, 
physicians and patients," says 
N o r m a n G. Levinsky, M . D . , 
Director of the Lvans Depart-
ment of Medicine. "Formerly, 
scientists had l i t t l e or no contact 
w i t h patients or physicians." 
"What is most significant 
about this laboratory, aside f r o m 
its open design w h i c h allows for 
increased efficiency i n conduct-
ing research, is that i t is a reaffir-
m a t i o n by the Lvans Medical 
Foundation and the Hospital of 
the importance of basic science 
as i t applies to c l inical medicine," 
says M u r p h y . 
Michael R. Paskavitz 
m FOR YOUR INFORMATION 
Dr. Murphy is 
the chief of the 
Section of 
Biomolecular 
Medicine at the 
University 
Hospital. He 
also is a professor of medicine at 
Boston University School of 
Medicine. 
Dr. Mc-
Caffrey is chief 
of the Section of 
Medical Oncol-
ogy at the 
University 
Hospital, and is 
a professor of medicine at the 
School of Medicine. 
If you would like more infor-
mation on the IL-2 toxin, or on 
medical oncology or 
biomolecular medicine services 
at the University Hospital, 
please call 1-800-842-3648. 
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FACING THE FACTS 
UH Skin Oncology Program 
responds to a rise in the number 
of skin tumors and cancers 
BY P A U L A A. G I L U G A N 
f ven w i t h a greater public awareness of the causes of sk in can-cer, approximately 400,000 new cases are 
diagnosed each year—an estimate 
that exceeds the combined n u m -
ber of a l l other cancers. Of fur-
ther concern is the steady i n -
crease i n cases of complex sk in 
tumors, w h i c h has prompted 
physicians at the Univers i ty 
Hospital to create a Skin Oncol-
ogy Program. 
"Clearly the incidence of sk in 
cancer is on the rise and that is a 
concern," says Program co-direc-
tor Gary S. Rogers, M . D . "But we 
also are seeing more patients w h o 
have complex tumors that need 
the expertise of several 
specialists. We don't exactly 
know w h y we're seeing more of 
these patients, but we believe 
this program w i l l opt imize their 
care." 
The majori ty of sk in tumors 
are of u n k n o w n origin, or they 
develop as a result of severe sk in 
cancer, such as malignant 
melanoma. But other sk in 
tumors have been associated w i t h 
heredity, exposure to chemical 
agents l ike arsenic, and i m -
munosupression, as i n the case of 
high-risk organ transplant 
patients. Approximately 90 to 95 
percent of sk in tumors appear on 
the face and neck. 
Some sk in cancers are superfi-
cial and spread main ly along the 
sk in surface, and they can be 
dealt w i t h through topical 
medication or surgical removal of 
the tumor . But other tumors, 
such as invasive carcinomas, 
carry a threat of invading deeper 
tissues i n the body, inc luding the 
eyes, bone, the sinuses, and the 
m o u t h . Mal ignant melanoma car-
ries a significant r isk of spreading 
to internal organs. Treatment of 
sk in cancer may require the i n v o l -
vement of several different medi-
cal specialties. 
The U H Skin Oncology 
Program takes advantage of a key 
attr ibute of teaching hospitals, 
the abi l i ty to bring in to play 
specialists i n a m u l t i t u d e of dis-
ciplines. For example, a patient 
w h o has a cancerous t u m o r of the 
eyelid or invading the muscula-
ture of the eye w o u l d l i k e l y un-
dergo Mobs surgery—a micros-
copically controlled method of 
surgery, highly effective i n treat-
ing certain sk in cancers—and 
then w o u l d undergo reconstruc-
t i o n by an oculoplastic surgeon, 
w h o w o u l d repair the funct ional 
and cosmetic damage to the eye. 
The Univers i ty Hospital is one 
of only 50 U.S. medical centers to 
have a Mobs surgery program, 
and U H is the only i n s t i t u t i o n i n 
the country to integrate Mobs 
surgery w i t h an ambulatory surgi-
cal center. 
The program's staff includes 
experts f r o m several disciplines, 
so that the patient can receive 
the f u l l range of evaluation and 
treatment under one roof. The 
Skin Oncology Program is unique 
i n that its mul t id isc ip l inary ap-
proach addresses a l l the needs 
that a patient afflicted w i t h the 
disease may have. 
How the program works 
Heading the Skin Oncology 
Program are Howard Koh, M . D . , 
F.A.C.P., and Rogers, of the 
Hospital 's Department of Der-
matology. As dermatologists, 
they already had been treating un-
usual and medically complex 
skin cancers, part icularly malig-
nant melanoma. Both have a spe-
cial expertise i n sk in oncology, 
'We don't 
m o w why 
we're seeing 
more patients 
w i t h complex 
skin tumors' 
Koh holds a jo int appointment i n 
medicine, and Rogers i n surgery. 
Koh heads the medical port ion of 
the Program; he directs the 
photopheresis u n i t at U H for 
patients w i t h cutaneous T-cel l 
lymphoma/Sezary's syndrome—a 
severe f o r m of sk in cancer that 
migrates in to the bloodstream, 
causing leukemia. Rogers runs 
the dermatoiogic surgery 
program, w h i c h specializes i n 
Mobs surgery. 
Both physicians are active i n 
c l inical sk in cancer research. 
Rogers is involved i n researching 
oncogene (cancer causing genes) 
act ivat ion i n sk in cancer, and is 
studying qual i ty of l ife and mor-
b id i ty i n facial cancer patients. 
"About a year ago, we decided 
to formalize our activities and es-
tablish the Program, since our i n -
terests and expertise comple-
mented each other," explains 
Koh. "Most of the patients that 
each of us saw had complex 
problems and required extensive 
care," says Rogers. "Our idea was 
to integrate the method of treat-
ment so the patient could be 
treated i n one place." 
A l l patients are referred to the 
Skin Oncology Program by other 
physicians, most often their 
pr imary care physician. The 
patient's condit ion may have al-
ready been diagnosed by his or 
her physician, or i t may need to 
be evaluated. Patients are treated 
on both an inpatient and out-
patient basis, depending on the 
severity of illness. 
If a sk in cancer, such as basal 
cell carcinoma, is diagnosed, 
surgery is often recommended. 
A l t h o u g h this particular type of 
cancer usually is not fatal, i t can 
invade and damage other tissues 
i n the body. For example, i f the 
original cancer site is found on 
the face, there is a chance the can-
cer may inf i l t ra te and invade an 
underlying structure, such as the 
sinuses. I n this case, Mohs 
surgery w o u l d be performed i n 
concert w i t h otolaryngology, and 
perhaps fo l lowed up by radiation 
medicine. 
Koh and Rogers have as-
sembled a team of more than 35 
physicians at U H , w h o have 
agreed to offer their expertise i n 
appropriate cases. Their areas i n -
clude dermatology, epidemiology, 
laboratory medicine, medical and 
surgical oncology, ophthalmol-
ogy, otolaryngology, pathology, 
plastic surgery, radiation 
medicine and social services. 
Education and prevention 
Preventive medicine, particularly 
for sk in cancer, can be very effec-
t ive i n decreasing the incidence 
of the disease. "The risk factors 
for sk in cancer are w e l l - k n o w n , " 
explains Koh, " w h i c h is w h y 
education and prevention are so 
important . " One of the goals of 
the program is to teach patients 
and patients' families ways to 
prevent the occurance of the dis-
ease, especially for those types of 
sk in cancers that may be 
hereditary. Fducating the public 
on how to d i m i n i s h the chance of 
getting sk in cancer and what to 
look for i n self-screening are 
other areas of emphasis. 
W i t h rising numbers of sk in 
cancer and complex sk in tumors 
i n the U.S., Koh and Rogers 
believe the involvement of many 
specialists w i l l be needed to offer 
sk in tumor patients opt imal 
results. " In the age of diverse 
specialization, this is a way to 
draw together a l l factions of 
physicians w h o treat the disease," 
says Rogers. 
• FOR YOUR INFORMATION 
Dr. Koh is a 
member of the 
staff of the 
University 
Hospital, and is 
an assistant 
professor of 
dermatology, medicine and 
public health at Boston 
University School of Medicine 
and School of Public Health. 
Dr. Rogers is 
a member of 
the U H Depart-
ment of Der-
matology, and 
is an assistant 
professor of 
dermatology and surgery at the 
School of Medicine. 
If you would like more infor-
mation on the Skin Oncology 
Program, or on related services 
at the University Hospital, 
please call 1-800-842-3648. 
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NAMES 
• On June 12, 1989, 
the Boston Univer-
sity Medical Center 
community suffered 
a great loss in the 
passing of Joseph 
Stokes III, M.D., a 
member of the Evans 
Department of 
Medicine's Section of Epidemiol-
ogy/Preventive Medicine and a co-
principal investigator of the renowned 
Framingham Heart Study. Dr. Stokes, 
who recently had been honored by his 
colleagues w i t h the prestigious Distin-
guished Service Award of the 
American College of Preventive 
Medicine, also was a professor of 
medicine and public health at Boston 
University School of Medicine and the 
School of Public Health, respectively. 
In addition to his Medical Center 
appointments. Stokes was an adjunct 
professor in the Nutrit ion Program at 
Sargent College of Allied Health 
Professions; a research associate at the 
Center for Educational Development 
in Health at Boston University, and a 
lecturer in the Department of Preven-
tive Medicine at Harvard Medical 
School. 
The editor of the American Journal 
of Preventive Medicine, Stokes pre-
viously was an associate editor of the 
New England Journal of Medicine and 
also was the former dean of the medi-
cal school at University of California 
at San Diego. 
• James S. Hoyte, 
former Mas-
sachusetts Secretary 
of Environmental Af-
fairs from 1983 
through 1988, has 
been elected to the 
Hospital's Board of 
Trustees. 
Hoyte, who currently works for the 
environmental law group of Choate, 
Hall St Stewart, is a graduate of the 
Kennedy School of Government of 
Harvard University, and also received 
his undergraduate and law degrees 
from Harvard. Prior to his state 
cabinet appointment, he was a vice 
president of a subsidiary company of 
Arthur D. Little, Inc., and also was 
secretary-treasurer of the Mas-
sachusetts Port Authority (Massport). 
• Richard A. Cohen, 
M.D. , a member of 
the Hospital's 
Peripheral Vascular 
Section of the Depart-
ment of Medicine, 
was elected president 
of the American 
Federation of Clini-
cal Research (AFCR), a prestigious na-
tional organization representing more 
than 12,000 clinical and basic re-
search scientists. Cohen, who is on 
the editorial boards of the American 
Journal of Physiology and Heart and 
Circulatory Physiology, w i l l serve as 
president-elect unti l he begins his 
term as president next year. 
• Karen K. Kirby, 
R .N., senior vice 
president for Nursing 
at UH, was awarded 
the eighth annual 
Mary B. Conceison 
Award of the Mas-
sachusetts Organiza-
tion of Nurse Execu-
tives (MONE) for outstanding contribu-
tions made as a nursing administrator. 
Kirby is MONE's immediate past presi-
dent; she has been the Hospital's 
senior nursing executive since 1983. 
• 
Jerome H. 
I Shapiro, M.D., chief 
of the Department of 
Radiology at U H and 
professor and chair-
Depart-
.fdMjKj^n iFient of Radiology at 
dBtSt ^ ^Bm Boston University 
School of Medicine, 
was recently named president-elect of 
the American College of Radiology 
(ACR), a prestigious national organiza-
tion of radiologists. Shapiro, who has 
received numerous distinctions in 
the field of diagnostic radiology, w i l l 
assume the office of president of the 
ACR next year. A graduate of Yale 
University School of Medicine, 
Shapiro has been at Boston Univer-
sity School of Medicine since 1963. 
NEWS 
• With a theme of "The Golden 
Days of Radio," the University 
Hospital's 12th Annual Gala Event 
proved a trerriendous success as more 
than $65,000 in net proceeds were 
raised to support UH's Annual Fund. 
The black-tie affair, held in the 
America Ballroom of the Westin 
Hotel at Copley Place, was attended 
by nearly 500 U H supporters and 
generated the largest amount of cor-
porate sponsors ever. 
Hosted by Ron Delia Chiesa of 
WGBH's "MusicAmerica," the gala 
Eight to the Bar provided the evening's 
dance music 
fundraiser took guests on a journey 
hack to the 1940s by recreating a live 
radio broadcast. Among the per-
formers that evening were profes-
sional storyteller Jay O'Callahan, 
New York City cabaret singer Carol 
Abercrombie, and the Boston Arts 
Group, who performed a live version 
of the famous radio show, "The 
Shadow." Dance music was provided 
by the swing band Tuxedo and the 
show band Light to the Bar. 
• At the Hospital's first conference 
on cultural diversity in the 
workplace, former New York Con-
gresswoman Shirley Chisholm 
delivered a strong message that called 
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for sensitivity and willingness to 
change as key factors in creating a 
culturally diverse workplace. 
Chisholm, the first black woman 
elected to the United States Congress 
and the first black woman to run for 
the Presidency, was the keynote 
speaker at the full-day conference, 
which was held in the Hospital's 
Keefer auditorium. Using statistics 
and anecdotes, as well as candor and 
humor, Chisholm spoke strongly 
about her topic, "Unity and Diver-
sity." She concluded her message by 
stating, "We must recognize that in 
America, we are all related. We are 
all fellow travelers on the same Earth 
trip." The University Hospital has 
been cited for leadership in creating a 
culturally diverse workplace. 
IN THE NEWS 
Since the last issue of Progress, the 
following University Hospital and/or 
Boston University School of 
Medicine health professionals have 
appeared in the media as expert sour-
ces for news stories: 
Caspar W. Anastasi, M.D., chief. 
Department of Plastic Surgery, was 
quoted in a Good Housekeeping ar-
ticle on removing 
scars and 
birthmarks Anna 
Bissonnette, R.N., 
Home Medical Ser-
vice, was the sub-
ject of a Waltham 
News-Tribune fea-
ture article about 
her work wi th the 
elderly community Edith De-
Vegvar, Social Services, was quoted 
in a Boston Globe article concerning 
a new program for caretakers of the 
elderly Richard A. Cohen, M.D., 
Section of Peripheral Vascular 
Medicine, was quoted in an As-
sociated Press (AP) story on vascular 
problems relating to Boston Red Sox 
pitcher Oil Can Boyd's arm in-
jury Richard H. Egdahl, M.D., direc-
tor, Boston University Medical 
Center, was interviewed for a WBZ-
TV Channel 4 news report on medi-
cal resident's hours in Mas-
sachusetts R. Curtis Ellison, M.D., 
chief. Section of Preventive Medicine/ 
Epidemiology, appeared in an As-
sociated Press (AP) and New Bedford 
Standard-Times stories on low 
Eiiison 
Giichrest 
cholesterol diets for kids, and in the 
Boston Globe concerning his low-fat 
breakfast research David P. Faxon, 
M.D., Section of Cardiology, ap-
peared in a Providence Sunday Jour-
nal article on intra-
arterial lasers as a 
possible therapy 
for atheroscler-
osis Merrill I. 
, Feldman, M.D., 
chief. Department 
I of Radiation 
Medicine, was 
named as one of the 
country's top radiation oncologists by 
200 medical school faculty members 
in a Good Housekeeping article on 
"The 184 Best Breast Cancer Doc-
tors." He also appeared in a New 
York Times article and on WXLO-FM 
radio (San Francisco) concerning his 
involvement in a study on the 
benefits of chemotherapy in early-
stage breast cancer Edward Fischer, 
M.D., Department of Neurosurgery, 
was quoted in a Boston Globe article 
about the Boston Medflight emergen-
cy helicopter service Thomas F. 
Freddo, O.D., Department of Ophthal-
mology, appeared in Boston Herald 
and Boston Globe Magazine articles 
on sunglasses Barbara A. Giichrest, 
M.D., chief. Department of Dermatol-
ogy, was interviewed for a Waterbmy 
(CT) Republican article on skin 
safety and the sun Donald R. 
Ciller, vice president, Market-
ing/Planning/Public Affairs, was 
quoted in Boston Herald and Boston 
Business Journal articles on the fiscal 
plight of Massachusetts hospitals, 
and was quoted in an American Medi-
cal News article on trends in health-
care marketing and advertis-
ing Paul J. Hesketh, M.D., Section 
of Medical Oncol-
ogy, was in USA 
Today, Boston 
Herald and Boston 
Globe articles on 
his work wi th a 
new antivomiting 
agent for 
chemotherapy 
patients Michael 
Holick, Ph.D., M.D., head. Metabolic 
Bone Disease Clinic, was quoted in a 
Health magazine story about vitamin 
D treatment for psoriasis, and in a 
Sunday Telegraph (Hudson, NH) ar-
ticle on vitamin D and bone 
loss Robert E. Leach, M.D., chief. 
Moskowitz 
Ryan 
Department of Orthopedic Surgery, 
was quoted in a Boston Globe article 
on the longevity of professional ath-
letes, and was interviewed for Boston 
Globe and Boston Herald articles on 
his patient, marathoner Joan Benoit-
Samuelson Lawrence J. Markson, 
M.D., Division of Medicine, was in-
terviewed by the Boston Globe and 
Channel 2 for stories on living 
wills Mark A. Moskowitz, M.D., 
head. Section of Internal Medicine, 
appeared in USA Today and Boston 
Globe articles on physician roles in 
patient decision-making, and also 
was featured in a Boston Herald ar-
ticle on knowing when you're sick 
enough to stay home from work, and 
appeared as well in a Daily Times-
Chronicle (Woburn) article on the 
need for more out-
patient training 
among doc-
tors John R. 
Mnrphy, Ph.D., 
chief. Section of 
Biomolecular 
Medicine, was in-
terviewed for 
Patriot Ledger 
(Quincy) and Medi-
cal World News articles on his IL-2 
toxin's potential use in leukemia and 
lymphoma patients Joseph Pictra-
fitta, M.D., Section of Surgical Oncol-
ogy, appeared in a Norwell Mariner ar-
ticle on his research in treating 
esophageal cancer with 
lasers Thomas J. Ryan, M.D., chief. 
Section of Cardiology, was inter-
viewed for a Washington Post article 
on coronary angioplasty in post-heart 
attack victims, and he appeared in a 
Boston Globe story about heart care 
for different races Inigo Saenz de 
Tejada, M.D., Department of Urol-
ogy, appeared in USA Today and 
Hartford Courant stories on his re-
search with impotency in diabetic 
men Marie Saint-Hilaire, M.D., 
and Linda Perry, R .N., Department of 
Neurology, appeared on a WODS-FM 
radio program, and were mentioned 
in Boston Globe, Patriot Ledger 
(Quincy) and Boston Seniority ar-
ticles, about the Hospital's 
Parkinson's Disease Day Program 
Don T. Tan, M.D., Department of 
Dermatology, was featured in Wor-
cester Sunday Telegram and Haver-
hill Gazette stories on treating 
portwine stains wi th lasers. 
P R O G R E S S 77 
The University Hospital 
at Boston University 
Medical Center 
88 East Newton Street 
Boston MA 02118 
Nonprofit Organization 
U.S. POSTAGE 
PAID 
Boston, MA 
PERMIT N O . 3469 
There are an estimated 10$ mil Hon workers in the 
United States. While most people 
associate occupational health hazards with 
"dangerous" jobs, like high-rise comtructim and 
hazardous waste clean-up, nmrfy merf worker is 
likelf to be exposed to some 
sort of work-related health or safety risk 
in their workplace. Ms the field ofoccu-
:. pational health has ewolwed, emplofers hawe cmw 
to realize that the cost of keeping their emplo fees 
,: •• healthf, safe and fit at work is the most sound 
investment they can make. By working with business 
" - = • ; • • ' and industry, the 
Uniwersity Hospitats Occupational 
Health Program Is doing its 
part, through patient care, 
medical eiumtion and research 
to make "punching the clock" 
a healthy and safe mpermme. 
See story page 8. 
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